Advertisement
Table 4 Baseline factors associated with successful treatment outcome (VS/IS)
| Baseline characteristic | Unadjusted OR (95% CI) | Adjusted OR (95% CI)† |
|---|---|---|
| Age > 18 months (vs < 18 mths) | 1.07 (0.39 - 2.96) | 4.6 (1.14 -19.1)* |
| Sex Male (vs Female) | 0.91 (0.44 - 1.91) | 0.71 (0.27 - 1.85) |
| CD4 cell % >10% (vs ≤ 10%) | 7.04 (3.07 - 16.19)** | 6.97 (2.6 - 18.6)** |
| HIV-1 RNA (copies/ml) < 750,000 (vs ≥ 750,000) | 1.95 (0.51 - 7.51) | 1.42 (0.29 - 6.98) |
| WHO stage 1&2 (vs 3) | 2.21 (0.93 - 5.24) | 3.50 (1.05 - 12.7)* |
| WAZ ≤ -2 (vs ≥ -2) | 0.48 (0.20 -1.13) | 0.50 (0.14 -1.78) |
| HAZ ≤ -2 (vs > -2) | 0.79 (0.38 - 1.66) | 1.19 (0.39 - 3.65) |
